EE9600180A - Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine - Google Patents
Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamineInfo
- Publication number
- EE9600180A EE9600180A EE9600180A EE9600180A EE9600180A EE 9600180 A EE9600180 A EE 9600180A EE 9600180 A EE9600180 A EE 9600180A EE 9600180 A EE9600180 A EE 9600180A EE 9600180 A EE9600180 A EE 9600180A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- hiv composition
- hiv
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94201897 | 1994-07-01 | ||
| PCT/EP1995/002462 WO1996001110A2 (en) | 1994-07-01 | 1995-06-23 | Anti-hiv triple combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9600180A true EE9600180A (et) | 1997-06-16 |
Family
ID=8217000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9600180A EE9600180A (et) | 1994-07-01 | 1995-06-23 | Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0768881B1 (et) |
| JP (1) | JP2945481B2 (et) |
| KR (1) | KR100218495B1 (et) |
| CN (1) | CN1091599C (et) |
| AP (1) | AP9600896A0 (et) |
| AT (1) | ATE218867T1 (et) |
| AU (1) | AU693911B2 (et) |
| BG (1) | BG101175A (et) |
| BR (1) | BR9508201A (et) |
| CA (1) | CA2193489A1 (et) |
| CZ (1) | CZ375596A3 (et) |
| DE (1) | DE69527066T2 (et) |
| EE (1) | EE9600180A (et) |
| FI (1) | FI965292A7 (et) |
| HU (1) | HUT77720A (et) |
| IL (1) | IL114415A0 (et) |
| MX (1) | MX9700044A (et) |
| MY (1) | MY130597A (et) |
| NO (1) | NO965556L (et) |
| OA (1) | OA10341A (et) |
| PL (1) | PL317891A1 (et) |
| SK (1) | SK168196A3 (et) |
| TW (1) | TW401303B (et) |
| WO (1) | WO1996001110A2 (et) |
| ZA (1) | ZA955471B (et) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4088697A (en) * | 1996-08-26 | 1998-03-19 | Chiron Corporation | Postinfection human immunodeficiency virus (hiv) vaccination therapy |
| EP0872233A1 (en) * | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Antiretroviral compositions with improved bioavailability |
| MXPA02003182A (es) | 1999-09-24 | 2002-09-30 | Janssen Pharmaceutica Nv | Composiciones antivirales. |
| MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
| US9044509B2 (en) | 2006-02-03 | 2015-06-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibition of HIV infection through chemoprophylaxis |
| TWI494133B (zh) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | 重組用粉末 |
| US8481554B2 (en) | 2009-05-27 | 2013-07-09 | Hetero Research Foundation | Solid oral dosage forms of lamivudine |
| WO2018119371A1 (en) * | 2016-12-23 | 2018-06-28 | Temple University - Of The Commonwealth System Of Higher Education | Anti-flaviviridae activity of anti-retroviral non-nucleoside (nnrtis) and nucleoside reverse transcriptase inhibitors (nnrtis) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1787492A (en) * | 1991-05-16 | 1992-12-30 | Glaxo Group Limited | Antiviral combinations containing nucleoside analogs |
-
1994
- 1994-05-25 TW TW084105260A patent/TW401303B/zh active
-
1995
- 1995-06-23 AP APAP/P/1996/000896A patent/AP9600896A0/en unknown
- 1995-06-23 JP JP8503654A patent/JP2945481B2/ja not_active Expired - Fee Related
- 1995-06-23 SK SK1681-96A patent/SK168196A3/sk unknown
- 1995-06-23 DE DE69527066T patent/DE69527066T2/de not_active Expired - Fee Related
- 1995-06-23 MX MX9700044A patent/MX9700044A/es unknown
- 1995-06-23 EE EE9600180A patent/EE9600180A/et unknown
- 1995-06-23 AU AU29248/95A patent/AU693911B2/en not_active Ceased
- 1995-06-23 WO PCT/EP1995/002462 patent/WO1996001110A2/en active IP Right Grant
- 1995-06-23 FI FI965292A patent/FI965292A7/fi not_active Application Discontinuation
- 1995-06-23 HU HU9603627A patent/HUT77720A/hu unknown
- 1995-06-23 EP EP95924930A patent/EP0768881B1/en not_active Expired - Lifetime
- 1995-06-23 CZ CZ963755A patent/CZ375596A3/cs unknown
- 1995-06-23 CA CA002193489A patent/CA2193489A1/en not_active Abandoned
- 1995-06-23 BR BR9508201A patent/BR9508201A/pt not_active Application Discontinuation
- 1995-06-23 PL PL95317891A patent/PL317891A1/xx unknown
- 1995-06-23 CN CN95193943A patent/CN1091599C/zh not_active Expired - Fee Related
- 1995-06-23 AT AT95924930T patent/ATE218867T1/de not_active IP Right Cessation
- 1995-06-30 MY MYPI95001822A patent/MY130597A/en unknown
- 1995-06-30 IL IL11441595A patent/IL114415A0/xx unknown
- 1995-06-30 ZA ZA955471A patent/ZA955471B/xx unknown
-
1996
- 1996-12-23 NO NO965556A patent/NO965556L/no unknown
- 1996-12-27 KR KR1019960707474A patent/KR100218495B1/ko not_active Expired - Fee Related
- 1996-12-31 OA OA60946A patent/OA10341A/en unknown
-
1997
- 1997-01-27 BG BG101175A patent/BG101175A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK168196A3 (en) | 1997-05-07 |
| CZ375596A3 (en) | 1997-04-16 |
| FI965292A0 (fi) | 1996-12-31 |
| WO1996001110A2 (en) | 1996-01-18 |
| CN1091599C (zh) | 2002-10-02 |
| MY130597A (en) | 2007-07-31 |
| JPH09507858A (ja) | 1997-08-12 |
| EP0768881B1 (en) | 2002-06-12 |
| AU2924895A (en) | 1996-01-25 |
| DE69527066D1 (de) | 2002-07-18 |
| KR100218495B1 (en) | 1999-09-01 |
| AU693911B2 (en) | 1998-07-09 |
| WO1996001110A3 (en) | 1996-02-22 |
| FI965292L (fi) | 1996-12-31 |
| BG101175A (bg) | 1997-08-29 |
| PL317891A1 (en) | 1997-04-28 |
| ATE218867T1 (de) | 2002-06-15 |
| CN1151697A (zh) | 1997-06-11 |
| FI965292A7 (fi) | 1996-12-31 |
| IL114415A0 (en) | 1995-10-31 |
| OA10341A (en) | 1997-10-07 |
| CA2193489A1 (en) | 1996-01-18 |
| NO965556D0 (no) | 1996-12-23 |
| TW401303B (en) | 2000-08-11 |
| NO965556L (no) | 1996-12-23 |
| BR9508201A (pt) | 1997-11-11 |
| HU9603627D0 (en) | 1997-02-28 |
| ZA955471B (en) | 1996-12-30 |
| MX9700044A (es) | 1997-04-30 |
| EP0768881A2 (en) | 1997-04-23 |
| JP2945481B2 (ja) | 1999-09-06 |
| AP9600896A0 (en) | 1997-01-31 |
| DE69527066T2 (de) | 2003-02-13 |
| HUT77720A (hu) | 1998-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962927A7 (fi) | Tetrasykliinijohdannaisia, valmistusmenetelmä ja käyttö | |
| FI962917A7 (fi) | Mikrokapselit, menetelmä niiden valmistamiseksi, ja niiden käyttö | |
| FI972164A7 (fi) | Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö | |
| FI972165L (fi) | Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö | |
| FI955235L (fi) | Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö | |
| EE03338B1 (et) | Tromboosivastane ravim, selle valmistamise protsess ja kasutamine | |
| EE9700310A (et) | N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine | |
| EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
| FI951468L (fi) | Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| FI964311L (fi) | Bifunktionaalinen proteiini, valmistus ja käyttö | |
| EE9800136A (et) | Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine | |
| EE03409B1 (et) | Kõrge efektiivsusega segusti ja selle valmistamise meetod | |
| FI963183A7 (fi) | Vesipitoinen dispersiokoostumus, ja sitä käyttävä koostumus | |
| FI935465L (fi) | Termoplastinen koostumus, menetelmä sen valmistamiseksi ja sen käyttö | |
| FI971861A7 (fi) | Puristuskoostumus, valmistusmenetelmä, puristusmenetelmä ja puristustu otteita | |
| FI970094L (fi) | Substituoidut bentsamidiinit, niiden valmistus ja käyttö lääkeaineena | |
| FI971268A7 (fi) | Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi | |
| FI970997A7 (fi) | Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö | |
| FI944182A7 (fi) | Yhtenäiskiteitä sisältävä koostumus, menetelmä sen valmistamiseksi ja sen käyttö | |
| EE04087B1 (et) | Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode | |
| FI954946L (fi) | Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| EE03387B1 (et) | Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks | |
| EE9600180A (et) | Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine | |
| FI953956L (fi) | 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| EE03798B1 (et) | Söödalisandi valmistamise meetod, söödalisand ja selle kasutamine |